The potential roles of nanobiomaterials in distraction osteogenesis

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 11, Issue 1, 2015, Pages 1-18

  Makhdom, Asim M ^a,b   Nayef, Lamees ^a   Tabrizian, Maryam ^a   Hamdy, Reggie C ^c  

^a MCGILL UNIVERSITY   (Canada)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^c MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

Bone healing; Bone regeneration; Delivery system; Distraction osteogenesis; Nanobiomaterials; Nanoparticles; Nanotechnology

Indexed keywords

MECHANICAL PROPERTIES; NANOCOMPOSITES; NANOPARTICLES; NANOTECHNOLOGY; SCAFFOLDS (BIOLOGY);

BONE HEALING; BONE REGENERATION; DELIVERY SYSTEMS; DISTRACTION OSTEOGENESIS; NANOBIOMATERIALS;

BONE;

GROWTH FACTOR; NANOCOMPOSITE; NANOPARTICLE; BIOMATERIAL; NANOMATERIAL; SIGNAL PEPTIDE;

BIOMECHANICS; BONE MARROW DERIVED MESENCHYMAL STEM CELL; BONE REGENERATION; DISTRACTION OSTEOGENESIS; DRUG DELIVERY SYSTEM; ENVIRONMENTAL ENRICHMENT; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; NONHUMAN; PROTEIN EXPRESSION; REVIEW; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE SCAFFOLD; ANIMAL; BONE; CELL TRANSPLANTATION; CHEMISTRY; DEVICES; EXTERNAL FIXATOR; GENE TRANSFER; NANOMEDICINE; PATHOLOGY; PROCEDURES;

ANIMALS; BIOCOMPATIBLE MATERIALS; BONE AND BONES; BONE REGENERATION; CELL TRANSPLANTATION; DRUG DELIVERY SYSTEMS; EXTERNAL FIXATORS; GENE TRANSFER TECHNIQUES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NANOCOMPOSITES; NANOMEDICINE; NANOPARTICLES; NANOSTRUCTURES; OSTEOGENESIS, DISTRACTION;

EID: 84919838208     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2014.05.009     Document Type: Review

References (144)

1. Harvey E., Henderson J., Vengallatore S. Nanotechnology and bone healing. J Orthop Trauma 2010, 24(Suppl. 1):S25-S30.
2. Dimitriou R., Jones E., McGonagle D., Giannoudis P.V. Bone regeneration: current concepts and future directions. BMC Med 2011, 9:66. [Epub 2011/06/02].
3. Nauth A., McKee M.D., Einhorn T.A., Watson J.T., Li R., Schemitsch E.H. Managing bone defects. J Orthop Trauma 2011, 25(8):462-466. [Epub 2011/07/09].
4. Desai B.M. Osteobiologics. Am J Orthop (Belle Mead NJ) 2007, 36(4 Suppl.):8-11. [Epub 2007/06/06].
5. Giannoudis P.V., Dinopoulos H., Tsiridis E. Bone substitutes: an update. Injury 2005, 36(Suppl. 3):S20-S27. [Epub 2005/09/29].
6. Ai-Aql Z., Alagl A., Graves D., Gerstenfeld L., Einhorn T. Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis. J Dent Res 2008, 87(2):107-118.
7. Hamdy R., Rendon S., Tabrizian M. Distraction Osteogenesis and Its Challenges. Bone Regeneration, Bone Regeneration 2012, InTech, Available from: http://www.intechopen.com/books/bone-regeneration/distraction-osteogenesis-and-itschallenges-in-bone-regeneration. H. Tal (Ed.).
8. Kasaai B., Moffatt P., Al-Salmi L., Lauzier D., Lessard L., Hamdy R.C. Spatial and temporal localization of WNT signaling proteins in a mouse model of distraction osteogenesis. J Histochem Cytochem 2012, 60(3):219-228. [Epub 2012/02/24].
9. Baek W.Y., Lee M.A., Jung J.W., Kim S.Y., Akiyama H., de Crombrugghe B., et al. Positive regulation of adult bone formation by osteoblast-specific transcription factor osterix. J Bone Miner Res 2009, 24(6):1055-1065. [Epub 2008/12/31].
10. Makhdom A.M., Hamdy R.C. The role of growth factors on acceleration of bone regeneration during distraction osteogenesis. Tissue Eng B Rev 2013, 19(5):442-453.
11. Huang C., Ogawa R. Mechanotransduction in bone repair and regeneration. FASEB J 2010, 24(10):3625-3632. [Epub 2010/05/28].
12. Aronson J. Experimental and clinical experience with distraction osteogenesis. Cleft Palate Craniofac J 1994, 31(6):473-481. [discussion 81-2; Epub 1994/11/01].
13. Birch J., Samchukov M. Use of the Ilizarov method to correct lower limb deformities in children and adolescents. J Am Acad Orthop Surg 2004, 12(3):144-154.
14. Cierny G., Zorn K.E. Segmental tibial defects. Comparing conventional and Ilizarov methodologies. Clin Orthop Relat Res 1994, 301:118-123. [Epub 1994/04/01].
15. Velazquez R., Bell D., Armstrong P., Babyn P., Tibshirani R. Complications of use of the Ilizarov technique in the correction of limb deformities in children. J Bone Joint Surg Am 1993, 75(8):1148-1156.
16. Eldridge J., Bell D. Problems with substantial limb lengthening. Orthop Clin North Am 1991, 22(4):625-631.
17. Sponer P., Kucera T., Diaz-Garcia D., Filip S. The role of mesenchymal stem cells in bone repair and regeneration. Eur J Orthop Surg Traumatol 2014, 24(3):257-262.
18. Yonezawa H., Harada K., Ikebe T., Shinohara M., Enomoto S. Effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on bone consolidation on distraction osteogenesis: a preliminary study in rabbit mandibles. J Craniomaxillofac Surg 2006, 34(5):270-276.
19. Mandu-Hrit M., Haque T., Lauzier D., Kotsiopriftis M., Rauch F., Tabrizian M., et al. Early injection of OP-1 during distraction osteogenesis accelerates new bone formation in rabbits. Growth Factors 2006, 24(3):172-183.
20. Ozkan K., Eralp L., Kocaoglu M., Ahishali B., Bilgic B., Mutlu Z., et al. The effect of transforming growth factor beta1 (TGF-beta1) on the regenerate bone in distraction osteogenesis. Growth Factors 2007, 25(2):101-107.
21. Nielsen H., Andreassen T., Ledet T., Oxlund H. Local injection of TGF-beta increases the strength of tibial fractures in the rat. Acta Orthop Scand 1994, 65(1):37-41.
22. Ohashi S., Ohnishi I., Kageyama T., Fukuda S., Tsuchiya A., Imai K., et al. Effect of vascularity on canine distracted tibial callus consolidation. Clin Orthop Relat Res 2005, 438:253-259.
23. Mizumoto Y., Moseley T., Drews M., Cooper Vr., Reddi A. Acceleration of regenerate ossification during distraction osteogenesis with recombinant human bone morphogenetic protein-7. J Bone Joint Surg Am 2003, 85-A(Suppl. 3):124-130.
24. Moore D.C., Ehrlich M.G., McAllister S.C., Machan J.T., Hart C.E., Voigt C., et al. Recombinant human platelet-derived growth factor-BB augmentation of new-bone formation in a rat model of distraction osteogenesis. J Bone Joint Surg Am 2009, 91(8):1973-1984. [Epub 2009/08/05].
25. Kleinheinz J., Stratmann U., Joos U., Wiesmann H.P. VEGF-activated angiogenesis during bone regeneration. J Oral Maxillofac Surg 2005, 63(9):1310-1316. [Epub 2005/08/27].
26. Stewart K.J., Weyand B., van't Hof R.J., White S.A., Lvoff G.O., Maffulli N., et al. A quantitative analysis of the effect of insulin-like growth factor-1 infusion during mandibular distraction osteogenesis in rabbits. Br J Plast Surg 1999, 52(5):343-350. [Epub 2000/01/05].
27. Abbaspour A., Takata S., Sairyo K., Katoh S., Yukata K., Yasui N. Continuous local infusion of fibroblast growth factor-2 enhances consolidation of the bone segment lengthened by distraction osteogenesis in rabbit experiment. Bone 2008, 42(1):98-106. [Epub 2007/10/18].
28. Mehta M., Schmidt-Bleek K., Duda G.N., Mooney D.J. Biomaterial delivery of morphogens to mimic the natural healing cascade in bone. Adv Drug Deliv Rev 2012, 64(12):1257-1276. [Epub 2012/05/26].
29. Lee K., Silva E.A., Mooney D.J. Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J R Soc Interf R Soc 2011, 8(55):153-170. [Epub 2010/08/20].
30. Zhang S., Uludag H. Nanoparticulate systems for growth factor delivery. Pharm Res 2009, 26(7):1561-1580. [Epub 2009/05/06].
31. Kim K., Fisher J.P. Nanoparticle technology in bone tissue engineering. J Drug Target 2007, 15(4):241-252. [Epub 2007/05/10].
32. Li X., Wang L., Fan Y., Feng Q., Cui F.Z., Watari F. Nanostructured scaffolds for bone tissue engineering. J Biomed Mater Res A 2013, 101A(8):2424-2435.
33. Yun Y., Jang J., Jeon E., Kang W., Lee S., Won J., et al. Administration of growth factors for bone regeneration. Regen Med 2012, 7(3):369-385.
34. Haque T., Hamade F., Alam N., Kotsiopriftis M., Lauzier D., St-Arnaud R., et al. Characterizing the BMP pathway in a wild type mouse model of distraction osteogenesis. Bone 2008, 42(6):1144-1153. [Epub 2008/03/29].
35. Campisi P., Hamdy R.C., Lauzier D., Amako M., Rauch F., Lessard M.L. Expression of bone morphogenetic proteins during mandibular distraction osteogenesis. Plast Reconstr Surg 2003, 111(1):201-208. [discussion 9-10; Epub 2002/12/24].
36. Rauch F., Lauzier D., Croteau S., Travers R., Glorieux F.H., Hamdy R. Temporal and spatial expression of bone morphogenetic protein-2, -4, and -7 during distraction osteogenesis in rabbits. Bone 2000, 26(6):611-617. [Epub 2000/06/01].
37. Haque T., Mandu-Hrit M., Rauch F., Lauzier D., Tabrizian M., Hamdy R.C. Immunohistochemical localization of bone morphogenetic protein-signaling Smads during long-bone distraction osteogenesis. J Histochem Cytochem 2006, 54(4):407-415. [Epub 2005/11/16].
38. Alam N., St-Arnaud R., Lauzier D., Rosen V., Hamdy R.C. Are endogenous BMPs necessary for bone healing during distraction osteogenesis?. Clin Orthop Relat Res 2009, 467(12):3190-3198. [Epub 2009/09/18].
39. Schumacher B., Albrechtsen J., Keller J., Flyvbjerg A., Hvid I. Periosteal insulin-like growth factor I and bone formation. Changes during tibial lengthening in rabbits. Acta Orthop Scand 1996, 67(3):237-241. [Epub 1996/06/01].
40. Yeung H.Y., Lee K.M., Fung K.P., Leung K.S. Sustained expression of transforming growth factor-beta1 by distraction during distraction osteogenesis. Life Sci 2002, 71(1):67-79. [Epub 2002/05/22].
41. Eingartner C., Coerper S., Fritz J., Gaissmaier C., Koveker G., Weise K. Growth factors in distraction osteogenesis. Immuno-histological pattern of TGF-beta1 and IGF-I in human callus induced by distraction osteogenesis. Int Orthop 1999, 23(5):253-259.
42. Hu J., Zou S., Li J., Chen Y., Wang D., Gao Z. Temporospatial expression of vascular endothelial growth factor and basic fibroblast growth factor during mandibular distraction osteogenesis. J Craniomaxillofac Surg 2003, 31(4):238-243. [Epub 2003/08/14].
43. Yeung H.Y., Lee S.K., Fung K.P., Leung K.S. Expression of basic fibroblast growth factor during distraction osteogenesis. Clin Orthop Relat Res 2001, 385:219-229. [Epub 2001/04/17].
44. Haidar Z., Hamdy R., Tabrizian M. Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part A: current challenges in BMP delivery. Biotechnol Lett 2009 Dec, 31(12):1817-1824.
45. Goldberg M.L.R., Jia X. Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym Ed 2007, 18(3):241-268.
46. Kofron M.D., Laurencin C.T. Bone tissue engineering by gene delivery. Adv Drug Deliv Rev 2006, 58(4):555-576. [Epub 2006/06/23].
47. Haidar Z., Hamdy R., Tabrizian M. Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part B: delivery systems for BMPs in orthopaedic and craniofacial tissue engineering. Biotechnol Lett 2009, 31(12):1825-1835.
48. Matassi F., Nistri L., Chicon Paez D., Innocenti M. New biomaterials for bone regeneration. Clin Cases Miner Bone Metab 2011, 8(1):21-24.
49. Mansouri S., Lavigne P., Corsi K., Benderdour M., Beaumont E., Fernandes J. Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy. Eur J Pharm Biopharm 2004, 57(1):1-8.
50. Rabinow B. Nanosuspensions in drug delivery. Nat Rev Drug Discov 2004, 3(9):785-796.
51. Parveen S., Misra R., Sahoo S.K. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine 2012, 8(2):147-166. [Epub 2011/06/28].
52. Zhang L., Gu F.X., Chan J.M., Wang A.Z., Langer R.S., Farokhzad O.C. Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther 2008, 83(5):761-769. [Epub 2007/10/25].
53. Ji W., Wang H., van den Beucken J.J., Yang F., Walboomers X.F., Leeuwenburgh S., et al. Local delivery of small and large biomolecules in craniomaxillofacial bone. Adv Drug Deliv Rev 2012, 64(12):1152-1164. [Epub 2012/03/21].
54. Couvreur P., Puisieux F. Nano- and microparticles for the delivery of polypeptides and proteins. Adv Drug Deliv Rev 1993, 10:141-162.
55. Shang L., Nienhaus K., Nienhaus G.U. Engineered nanoparticles interacting with cells: size matters. J Nanobiotechnol 2014, 12:5. [Epub 2014/02/05].
56. Moghimi S.M., Hunter A.C., Murray J.C. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 2001, 53(2):283-318. [Epub 2001/05/18].
57. Vinogradov S.V., Bronich T.K., Kabanov A.V. Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells. Adv Drug Deliv Rev 2002, 54(1):135-147. [Epub 2002/01/05].
58. Goldberg M., Langer R., Jia X. Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym Ed 2007, 18(3):241-268. [Epub 2007/05/03].
59. Kettler K., Veltman K., van de Meent D., van Wezel A., Hendriks A.J. Cellular uptake of nanoparticles as determined by particle properties, experimental conditions, and cell type. Environ Toxicol Chem 2014, 33(3):481-492. [Epub 2013/11/26].
60. Gu W., Wu C., Chen J., Xiao Y. Nanotechnology in the targeted drug delivery for bone diseases and bone regeneration. Int J Nanomedicine 2013, 8:2305-2317. [Epub 2013/07/10].
61. Ishizaki J., Waki Y., Takahashi-Nishioka T., Yokogawa K., Miyamoto K. Selective drug delivery to bone using acidic oligopeptides. J Bone Miner Metab 2009, 27(1):1-8. [Epub 2008/11/20].
62. Gu W.Y., Wu C.T., Chen J.Z., Xiao Y. Nanotechnology in the targeted drug delivery for bone diseases and bone regeneration. Int J Nanomedicine 2013, 8(1):2305-2317.
63. Sahana H., Khajuria D.K., Razdan R., Mahapatra D.R., Bhat M.R., Suresh S., et al. Improvement in bone properties by using risedronate adsorbed hydroxyapatite novel nanoparticle based formulation in a rat model of osteoporosis. J Biomed Nanotechnol 2013, 9(2):193-201. [Epub 2013/05/01].
64. Salerno M., Cenni E., Fotia C., Avnet S., Granchi D., Castelli F., et al. Bone-targeted doxorubicin-loaded nanoparticles as a tool for the treatment of skeletal metastases. Curr Cancer Drug Targets 2010, 10(7):649-659. [Epub 2010/06/29].
65. Zhang G., Guo B., Wu H., Tang T., Zhang B.T., Zheng L., et al. A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy. Nat Med 2012, 18(2):307-314. [Epub 2012/01/31].
66. Lee J.S., Go D.H., Bae J.W., Lee S.J., Park K.D. Heparin conjugated polymeric micelle for long-term delivery of basic fibroblast growth factor. J Control Release 2007, 117(2):204-209. [Epub 2007/01/02].
67. Eley J.G., Mathew P. Preparation and release characteristics of insulin and insulin-like growth factor-one from polymer nanoparticles. J Microencapsul 2007, 24(3):225-234. [Epub 2007/04/25].
68. Thomas T.P., Shukla R., Kotlyar A., Liang B., Ye J.Y., Norris T.B., et al. Dendrimer-epidermal growth factor conjugate displays superagonist activity. Biomacromolecules 2008, 9(2):603-609. [Epub 2008/01/16].
69. Usui Y., Aoki K., Narita N., Murakami N., Nakamura I., Nakamura K., et al. Carbon nanotubes with high bone-tissue compatibility and bone-formation acceleration effects. Small 2008, 4(2):240-246. [Epub 2008/01/22].
70. Park J., Ries J., Gelse K., Kloss F., von der Mark K., Wiltfang J., et al. Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes. Gene Ther 2003, 10(13):1089-1098. [Epub 2003/06/17].
71. Matsuo T., Sugita T., Kubo T., Yasunaga Y., Ochi M., Murakami T. Injectable magnetic liposomes as a novel carrier of recombinant human BMP-2 for bone formation in a rat bone-defect model. J Biomed Mater Res A 2003, 66(4):747-754. [Epub 2003/08/20].
72. Park Y, Dziak R, Genco R, Swihart M, Perinpanayagam H. Calcium sulfate based nanoparticles. US patent. 2007; 60/887,859.
73. Yang L., Webster T.J. Nanotechnology controlled drug delivery for treating bone diseases. Expert Opin Drug Deliv 2009, 6(8):851-864. [Epub 2009/07/30].
74. Meinel L., Illi O.E., Zapf J., Malfanti M., Peter Merkle H., Gander B. Stabilizing insulin-like growth factor-I in poly(D, L-lactide-co-glycolide) microspheres. J Control Release 2001, 70(1-2):193-202. [Epub 2001/02/13].
75. Lu L., Yaszemski M.J., Mikos A.G. TGF-beta1 release from biodegradable polymer microparticles: its effects on marrow stromal osteoblast function. J Bone Joint Surg Am 2001, 83-A(Suppl. 1(Pt 2)):S82-S91. [Epub 2001/04/21].
76. McCarron P.A., Marouf W.M., Donnelly R.F., Scott C. Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality. J Biomed Mater Res A 2008, 87(4):873-884. [Epub 2008/01/30].
77. Choi S.W., Kim J.H. Design of surface-modified poly(D, L-lactide-co-glycolide) nanoparticles for targeted drug delivery to bone. J Control Release 2007, 122(1):24-30. [Epub 2007/07/14].
78. Choi S.W., Kim W.S., Kim J.H. Surface-functionalized nanoparticles for controlled drug delivery. Methods Mol Biol 2005, 303:121-131. [Epub 2005/06/01].
79. Duceppe N., Tabrizian M. Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery. Expert Opin Drug Deliv 2010, 7(10):1191-1207. [Epub 2010/09/15].
80. Almeida A.J., Souto E. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Deliv Rev 2007, 59(6):478-490. [Epub 2007/06/05].
81. Cho K., Wang X., Nie S., Chen Z.G., Shin D.M. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 2008, 14(5):1310-1316. [Epub 2008/03/05].
82. Copland M.J., Rades T., Davies N.M., Baird M.A. Lipid based particulate formulations for the delivery of antigen. Immunol Cell Biol 2005, 83(2):97-105. [Epub 2005/03/08].
83. Bianco A., Kostarelos K., Partidos C.D., Prato M. Biomedical applications of functionalised carbon nanotubes. Chem Commun (Camb) 2005, (5):571-577. [Epub 2005/01/27].
84. Liu Z., Chen K., Davis C., Sherlock S., Cao Q., Chen X., et al. Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res 2008, 68(16):6652-6660. [Epub 2008/08/15].
85. Miyagawa H., Misra M., Mohanty A.K. Mechanical properties of carbon nanotubes and their polymer nanocomposites. J Nanosci Nanotechnol 2005, 5(10):1593-1615. [Epub 2005/10/26].
86. Spitalsky Z., Tasis D., Papagelis K., Galiotis C. Carbon nanotube-polymer composites: chemistry, processing, mechanical and electrical properties. Prog Polym Sci 2010, 35(3):357-401.
87. Bianco A., Kostarelos K., Prato M. Applications of carbon nanotubes in drug delivery. Curr Opin Chem Biol 2005, 9(6):674-679. [Epub 2005/10/20].
88. Yuan X., Naguib S., Wu Z. Recent advances of siRNA delivery by nanoparticles. Expert Opin Drug Deliv 2011, 8(4):521-536. [Epub 2011/03/19].
89. Jin S., Leach J.C., Ye K. Nanoparticle-mediated gene delivery. Methods Mol Biol 2009, 544:547-557. [Epub 2009/06/03].
90. Li Y., Wang J., Wientjes M.G., Au J.L. Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor. Adv Drug Deliv Rev 2012, 64(1):29-39. [Epub 2011/05/17].
91. Whitehead K.A., Langer R., Anderson D.G. Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov 2009, 8(2):129-138. [Epub 2009/01/31].
92. Perrien D.S., Brown E.C., Aronson J., Skinner R.A., Montague D.C., Badger T.M., et al. Immunohistochemical study of osteopontin expression during distraction osteogenesis in the rat. J Histochem Cytochem 2002, 50(4):567-574.
93. Yilgor P., Tuzlakoglu K., Reis R.L., Hasirci N., Hasirci V. Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering. Biomaterials 2009, 30(21):3551-3559.
94. Guo X., Zheng Q., Kulbatski I., Yuan Q., Yang S., Shao Z., et al. Bone regeneration with active angiogenesis by basic fibroblast growth factor gene transfected mesenchymal stem cells seeded on porous beta-TCP ceramic scaffolds. Biomed Mater 2006, 1(3):93-99. [Epub 2008/05/07].
95. Hosseinkhani H., Hosseinkhani M., Gabrielson N.P., Pack D.W., Khademhosseini A., Kobayashi H. DNA nanoparticles encapsulated in 3D tissue-engineered scaffolds enhance osteogenic differentiation of mesenchymal stem cells. J Biomed Mater Res A 2008, 85(1):47-60. [Epub 2007/08/11].
96. Krebs M.D., Salter E., Chen E., Sutter K.A., Alsberg E. Calcium phosphate-DNA nanoparticle gene delivery from alginate hydrogels induces in vivo osteogenesis. J Biomed Mater Res A 2010, 92(3):1131-1138. [Epub 2009/03/27].
97. Huang Y.C., Simmons C., Kaigler D., Rice K.G., Mooney D.J. Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4). Gene Ther 2005, 12(5):418-426. [Epub 2005/01/14].
98. Kwong F.N., Richardson S.M., Evans C.H. Chordin knockdown enhances the osteogenic differentiation of human mesenchymal stem cells. Arthritis Res Ther 2008, 10(3):R65. [Epub 2008/06/06].
99. Tuzlakoglu K., Bolgen N., Salgado A.J., Gomes M.E., Piskin E., Reis R.L. Nano- and micro-fiber combined scaffolds: a new architecture for bone tissue engineering. J Mater Sci Mater Med 2005, 16(12):1099-1104. [Epub 2005/12/20].
100. Chung H.J., Park T.G. Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering. Adv Drug Deliv Rev 2007, 59(4-5):249-262. [Epub 2007/05/08].
101. Yao C., Webster T.J. Anodization: a promising nano-modification technique of titanium implants for orthopedic applications. J Nanosci Nanotechnol 2006, 6(9-10):2682-2692. [Epub 2006/10/20].
102. Lee G.Y., Cheung K., Chang W., Lee L.P. In Mechanical interlocking with precisely controlled nano- and microscale geometries for implantable microdevices, Microtechnologies in Medicine and Biology. 1st Annual International, Conference 2000, 537-541.
103. Junker R., Dimakis A., Thoneick M., Jansen J.A. Effects of implant surface coatings and composition on bone integration: a systematic review. Clin Oral Implants Res 2009, 20(Suppl. 4):185-206. [Epub 2009/08/12].
104. Zhao L., Mei S., Chu P.K., Zhang Y., Wu Z. The influence of hierarchical hybrid micro/nano-textured titanium surface with titania nanotubes on osteoblast functions. Biomaterials 2010, 31(19):5072-5082. [Epub 2010/04/07].
105. Baker B.M., Chen C.S. Deconstructing the third dimension: how 3D culture microenvironments alter cellular cues. J Cell Sci 2012, 125(Pt 13):3015-3024. [Epub 2012/07/17].
106. Tian X.F., Heng B.C., Ge Z., Lu K., Rufaihah A.J., Fan V.T., et al. Comparison of osteogenesis of human embryonic stem cells within 2D and 3D culture systems. Scand J Clin Lab Invest 2008, 68(1):58-67. [Epub 2008/01/29].
107. Holzwarth J.M., Ma P.X. Biomimetic nanofibrous scaffolds for bone tissue engineering. Biomaterials 2011, 32(36):9622-9629. [Epub 2011/09/29].
108. Chan C.K., Kumar T.S., Liao S., Murugan R., Ngiam M., Ramakrishnan S. Biomimetic nanocomposites for bone graft applications. Nanomedicine (Lond) 2006, 1(2):177-188. [Epub 2007/08/25].
109. Khan Y., Yaszemski M.J., Mikos A.G., Laurencin C.T. Tissue engineering of bone: material and matrix considerations. J Bone Joint Surg Am 2008, 90(Suppl. 1):36-42. [Epub 2008/03/20].
110. Woo K.M., Chen V.J., Ma P.X. Nano-fibrous scaffolding architecture selectively enhances protein adsorption contributing to cell attachment. J Biomed Mater Res A 2003, 67(2):531-537. [Epub 2003/10/21].
111. Woo K.M., Jun J.H., Chen V.J., Seo J., Baek J.H., Ryoo H.M., et al. Nano-fibrous scaffolding promotes osteoblast differentiation and biomineralization. Biomaterials 2007, 28(2):335-343. [Epub 2006/07/21].
112. Xin X., Hussain M., Mao J.J. Continuing differentiation of human mesenchymal stem cells and induced chondrogenic and osteogenic lineages in electrospun PLGA nanofiber scaffold. Biomaterials 2007, 28(2):316-325. [Epub 2006/10/03].
113. Hu J., Feng K., Liu X., Ma P.X. Chondrogenic and osteogenic differentiations of human bone marrow-derived mesenchymal stem cells on a nanofibrous scaffold with designed pore network. Biomaterials 2009, 30(28):5061-5067. [Epub 2009/07/01].
114. Guo X., Park H., Young S., Kretlow J.D., van den Beucken J.J., Baggett L.S., et al. Repair of osteochondral defects with biodegradable hydrogel composites encapsulating marrow mesenchymal stem cells in a rabbit model. Acta Biomater 2010, 6(1):39-47. [Epub 2009/08/08].
115. Biondi M., Ungaro F., Quaglia F., Netti P.A. Controlled drug delivery in tissue engineering. Adv Drug Deliv Rev 2008, 60(2):229-242. [Epub 2007/11/23].
116. Balasundaram G. Nanomaterials for better orthopedics. Nanotechnology for the regeneration of hard and soft tissues 2007, World Scientific, Singapore. T.J. Webster (Ed.).
117. Lee S.H., Shin H. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. Adv Drug Deliv Rev 2007, 59(4-5):339-359. [Epub 2007/05/15].
118. Lichte P., Pape H.C., Pufe T., Kobbe P., Fischer H. Scaffolds for bone healing: concepts, materials and evidence. Injury 2011, 42(6):569-573. [Epub 2011/04/15].
119. Deng M., James R., Laurencin C.T., Kumbar S.G. Nanostructured polymeric scaffolds for orthopaedic regenerative engineering. IEEE Trans Nanobioscience 2012, 11(1):3-14. [Epub 2012/01/26].
120. Haidar Z.S., Hamdy R.C., Tabrizian M. Protein release kinetics for core-shell hybrid nanoparticles based on the layer-by-layer assembly of alginate and chitosan on liposomes. Biomaterials 2008, 29(9):1207-1215. [Epub 2007/12/14].
121. Haidar Z.S., Azari F., Hamdy R.C., Tabrizian M. Modulated release of OP-1 and enhanced preosteoblast differentiation using a core-shell nanoparticulate system. J Biomed Mater Res A 2009, 91(3):919-928. [Epub 2008/12/20].
122. Haidar Z.S., Hamdy R.C., Tabrizian M. Biocompatibility and safety of a hybrid core-shell nanoparticulate OP-1 delivery system intramuscularly administered in rats. Biomaterials 2010, 31(10):2746-2754. [Epub 2010/01/02].
123. Haidar Z.S., Tabrizian M., Hamdy R.C. A hybrid rhOP-1 delivery system enhances new bone regeneration and consolidation in a rabbit model of distraction osteogenesis. Growth Factors 2010, 28(1):44-55. [Epub 2009/12/02].
124. Wang L., Cao J., Lei D.L., Cheng X.B., Zhou H.Z., Hou R., et al. Application of nerve growth factor by gel increases formation of bone in mandibular distraction osteogenesis in rabbits. Br J Oral Maxillofac Surg 2010, 48(7):515-519. [Epub 2010/03/20].
125. Cho B.C., Kim J.Y., Lee J.H., Chung H.Y., Park J.W., Roh K.H., et al. The bone regenerative effect of chitosan microsphere-encapsulated growth hormone on bony consolidation in mandibular distraction osteogenesis in a dog model. J Craniofac Surg 2004, 15(2):299-311. [discussion 2-3; Epub 2004/05/29].
126. Chen F.M., Zhang M., Wu Z.F. Toward delivery of multiple growth factors in tissue engineering. Biomaterials 2010, 31(24):6279-6308. [Epub 2010/05/25].
127. Vonau R.L., Bostrom M.P., Aspenberg P., Sams A.E. Combination of growth factors inhibits bone ingrowth in the bone harvest chamber. Clin Orthop Relat Res 2001, 386:243-251. [Epub 2001/05/12].
128. Zhu S., Song D., Jiang X., Zhou H., Hu J. Combined effects of recombinant human BMP-2 and Nell-1 on bone regeneration in rapid distraction osteogenesis of rabbit tibia. Injury 2011, 42(12):1467-1473. [Epub 2011/06/28].
129. Zhang W.B., Zheng L.W., Chua D.T., Cheung L.K. Treatment of irradiated mandibles with mesenchymal stem cells transfected with bone morphogenetic protein 2/7. J Oral Maxillofac Surg 2012, 70(7):1711-1716. [Epub 2012/05/15].
130. Yeh L.C., Lee J.C. Co-transfection with the osteogenic protein (OP)-1 gene and the insulin-like growth factor (IGF)-I gene enhanced osteoblastic cell differentiation. Biochim Biophys Acta 2006, 1763(1):57-63. [Epub 2005/12/21].
131. Jiang J., Fan C.Y., Zeng B.F. Osteogenic differentiation effects on rat bone marrow-derived mesenchymal stromal cells by lentivirus-mediated co-transfection of human BMP2 gene and VEGF165 gene. Biotechnol Lett 2008, 30(2):197-203. [Epub 2007/09/27].
132. Laflamme C., Curt S., Rouabhia M. Epidermal growth factor and bone morphogenetic proteins upregulate osteoblast proliferation and osteoblastic markers and inhibit bone nodule formation. Arch Oral Biol 2010, 55(9):689-701. [Epub 2010/07/16].
133. Yilgor P., Sousa R.A., Reis R.L., Hasirci N., Hasirci V. Effect of scaffold architecture and BMP-2/BMP-7 delivery on in vitro bone regeneration. J Mater Sci Mater Med 2010, 21(11):2999-3008. [Epub 2010/08/27].
134. Yilgor P., Hasirci N., Hasirci V. Sequential BMP-2/BMP-7 delivery from polyester nanocapsules. J Biomed Mater Res A 2010, 93(2):528-536. [Epub 2009/07/09].
135. Kempen D.H., Lu L., Heijink A., Hefferan T.E., Creemers L.B., Maran A., et al. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials 2009, 30(14):2816-2825. [Epub 2009/02/24].
136. De la Riva B., Sanchez E., Hernandez A., Reyes R., Tamimi F., Lopez-Cabarcos E., et al. Local controlled release of VEGF and PDGF from a combined brushite-chitosan system enhances bone regeneration. J Control Release 2010, 143(1):45-52. [Epub 2009/12/08].
137. Long J., Li P., Du H., Liu L., Zheng X., Lin Y., et al. Effects of bone morphogenetic protein 2 gene therapy on new bone formation during mandibular distraction osteogenesis at rapid rate in rabbits. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011, 112(1):50-57.
138. Aykan A., Ozturk S., Sahin I., Gurses S., Ural AU., Oren NC., et al. Biomechanical analysis of the effect of mesenchymal stem cells on mandibular distraction osteogenesis. J Craniofac Surg 2013, 24(2):e169-e175. [Epub 2013/03/26].
139. Bressan E., Carraro A., Ferroni L., Gardin C., Sbricoli L., Guazzo R., et al. Nanotechnology to drive stem cell commitment. Nanomedicine (Lond) 2013, 8(3):469-486. [Epub 2013/03/13].
140. Shin M., Yoshimoto H., Vacanti J. In vivo bone tissue engineering using mesenchymal stem cells on a novel electrospun nanofibrous scaffold. Tissue Eng 2004, 10(1-2):33-41.
141. Smith L., Liu X., Hu J., Ma P. The enhancement of human embryonic stem cell osteogenic differentiation with nano-fibrous scaffolding. Biomaterials 2010, 31(21):5526-5535.
142. Wei G., Ma P. Structure and properties of nano-hydroxyapatite/polymer composite scaffolds for bone tissue engineering. Biomaterials 2004, 25(19):4749-4757.
143. Xu H., Smith D., Simon C. Strong and bioactive composites containing nano-silica-fused whiskers for bone repair. Biomaterials 2004, 25(19):4615-4626.
144. Hong Z., Zhang P., He C., Qiu X., Liu A., Chen L., et al. Nano-composite of poly(L-lactide) and surface grafted hydroxyapatite: mechanical properties and biocompatibility. Biomaterials 2005, 26(32):6296-6304. [Epub 2005/05/26].